The approach

A 90-day investigation
into your condition

Vestia correlates symptoms, hearing thresholds, and lifestyle data across 90 structured days — so you can see exactly what drives your condition, not just that it happened.

Hearing threshold (dBHL) · Low-frequency fluctuation AirPods Pro vs ENT audiogram — same patient, same day
NORMAL ZONE (0–25 dBHL) LOW-FREQ LOSS ZONE 250 500 1k 2k 4k 8k 0 20 40 60 80 AirPods Pro ENT clinic
Built by a cochlear hydrops patient
90-day structured programme
Free during beta
Beta testers: UK · US · Ireland · Australia
Who it's for

Two conditions.
One underlying mechanism.
One tool.

Ménière's disease and cochlear hydrops share the same root cause — endolymphatic hydrops — but patients face different diagnostic journeys, different clinical thresholds, and different levels of recognition. Vestia was built for both.

Ménière's disease

You have a formal diagnosis and know what a full attack feels like. The question isn't what's happening — it's why this Tuesday and not last Tuesday. What combination of factors tips you over the edge.

  • Identify your personal sodium and pressure sensitivity thresholds
  • Detect the lag between trigger exposure and episode onset
  • Track hearing fluctuation across frequencies between ENT visits
  • Build a 90-day evidence base to bring to your specialist

Cochlear hydrops

You may have been told your hearing is "borderline," that you don't yet meet the criteria for Ménière's, or that you should just "monitor it." You know something is wrong. Vestia helps you prove it — to yourself and to your clinical team.

  • Track the low-frequency fluctuation that defines cochlear hydrops
  • Document the aural fullness and distortion that clinical visits miss
  • Generate longitudinal data showing the pattern over months, not one snapshot
  • Understand your personal triggers before symptoms progress
The problem

You've been given generic advice
for a deeply personal condition.

Whether you have a full Ménière's diagnosis or are navigating the ambiguous early stages of cochlear hydrops, the advice is the same: reduce sodium, reduce stress. No one tells you which factors actually matter for you.

Without Vestia Ménière's

"Reduce sodium"You have no way to know whether it's the sodium or the pressure drop — or both together — that precedes your episodes. You're guessing at which days to be careful.

With Vestia Ménière's

Your pattern becomes visibleHigh sodium combined with a pressure drop below 1008 hPa precedes an episode within 18–24 hours in 73% of your logged instances. Now you can act on it.

Without Vestia Cochlear hydrops

"Your hearing is borderline"The ENT sees one audiogram per visit. The low-frequency fluctuation that defines your condition — sometimes 20–30dB in a single week — is completely invisible to them.

With Vestia Cochlear hydrops

Fluctuation becomes evidenceNinety days of threshold data at 250Hz, 500Hz, and 1kHz — showing the characteristic low-frequency dip and recovery pattern. Something a single clinical snapshot can never capture.

Without Vestia Both conditions

Appointments are snapshotsYou see a specialist for 15 minutes every 6–12 months. What you experienced on the 47 days between appointments is lost. Your clinical record doesn't reflect your actual condition.

With Vestia Both conditions

You walk in with evidenceA structured 90-day report — trigger correlations, hearing history, episode frequency — that transforms a 15-minute appointment into a clinically meaningful conversation.

How it works

Four layers.
One coherent picture.

01

Daily logging — 30 seconds

Symptoms, aural fullness, tinnitus intensity, sleep, sodium, caffeine, stress, and barometric pressure. Fast and structured — not an open diary.

02

Home audiogram tracking

Log hearing thresholds from Apple AirPods Pro or compatible apps. Vestia classifies results into clinical zones and tracks low-frequency fluctuation — the hallmark of both cochlear hydrops and Ménière's.

03

Trigger correlation engine

After sufficient data, Vestia identifies which variables correlate with your symptoms — including lag analysis to detect the 12–48 hour delay common in hydrops and Ménière's triggers.

04

AI-powered guidance

Ask questions about your own patterns. "Why was last Tuesday worse?" or "What does this pressure system mean for me?" Answered from your personal data, not generic advice.

Day 47 · Today's Log
Sodium2,400mg
Sleep7.2h
Pressure1004 hPa ↓
Aural fullnessModerate
250Hz threshold42 dBHL
Your top triggers
Pressure
0.88
Sodium
0.74
Sleep
0.61
Caffeine
0.38
Features

Built for the complexity
of endolymphatic hydrops

Trigger correlation engine

Dual-layer analysis across all logged variables, with lag detection. Sodium affects your endolymph over hours — not instantly. Vestia accounts for that delay.

Ménière's + hydrops

Low-frequency audiogram intelligence

Classifies threshold data at 250Hz and 500Hz — the frequencies most affected in cochlear hydrops — into clinical zones and tracks fluctuation patterns over weeks and months.

Critical for hydrops

Barometric pressure tracking

Automatic pressure logging via device sensors. A known but poorly-quantified trigger for both conditions — Vestia lets you test whether pressure sensitivity applies to you specifically.

Ménière's + hydrops

AI-powered guidance

Ask natural-language questions about your own data. Guidance is contextualised to your personal pattern — not generic dietary advice that ignores whether sodium is actually your trigger.

Ménière's + hydrops

90-day structured programme

A guided investigation framework, not an open diary. Weekly insights, milestone reviews, and a final report structured for a clinical conversation — not a wellness summary.

Ménière's + hydrops

ENT-ready export

A clinical summary of your trigger profile, hearing history, and episode frequency — formatted to make a 15-minute ENT appointment actually reflect 90 days of your condition.

Especially valuable for hydrops
FAQ

Common questions

Yes — and in many ways, Vestia is more immediately useful at the cochlear hydrops stage. The 90-day programme generates the kind of longitudinal data — fluctuating thresholds, trigger correlations, symptom patterns — that is most valuable when you're still trying to understand your condition and convince your clinical team to take it seriously. Many cochlear hydrops patients use the ENT-ready export to bring objective evidence to appointments that would otherwise be based on subjective description alone.
No. Vestia supports home audiogram input from Apple AirPods Pro and compatible third-party audiometry apps, as well as manual entry of clinical audiogram results. The value is in tracking your personal fluctuation consistently over time — not in clinical-grade precision on any single measurement. Comparative data from the same source, taken regularly, is more informative than sporadic clinical snapshots.
Typically 4–6 weeks of consistent daily logging, with at least 2–3 episodes or significant symptom events in that window. The correlation engine needs sufficient variance in both lifestyle data and symptom data to identify statistically meaningful patterns. The 90-day programme is designed around this timeline — early weeks focus on establishing baseline, later weeks on pattern analysis.
During the beta period, Vestia is completely free — no payment required. When we launch fully, plans will include a 90-day structured programme, a monthly subscription, and an annual subscription. Beta testers will receive priority early access and preferential pricing at launch.
No. Vestia is a personal tracking and pattern-analysis tool. It does not diagnose conditions, replace clinical audiometry, or provide medical advice. The AI guidance is informational and grounded in your personal logged data — it is designed to complement, not replace, your relationship with your ENT specialist or audiologist.
Aural fullness — the sensation of pressure or blockage in the ear — is caused by excess endolymph building up in the inner ear, distending the membranes of the cochlea and vestibular system. It often precedes a Ménière's episode or accompanies a period of low-frequency hearing deterioration in cochlear hydrops. Tracking aural fullness daily alongside sodium intake, barometric pressure, and sleep can help identify the specific conditions that trigger increases in endolymphatic pressure for you personally.
Fluctuating low frequency hearing loss at 250Hz and 500Hz is the hallmark of endolymphatic hydrops — the underlying mechanism of both cochlear hydrops and Ménière's disease. Thresholds fluctuate because endolymphatic pressure changes affect the mechanical properties of the cochlear membranes, particularly at low frequencies. Hearing can improve significantly during low-pressure periods and deteriorate during high-pressure periods, sometimes within the same day. Daily home audiometry reveals the pattern and can correlate it with sodium, stress, sleep, and barometric pressure data.
Ready to start?

Join the beta
waitlist

iOS · Free during beta · Limited places currently available

Join Beta Waitlist →